HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted concurrent chemoradiotherapy, by using improved microcapsules that release carboplatin in response to radiation, improves detectability by computed tomography as well as antitumor activity while reducing adverse effect in vivo.

AbstractPURPOSE:
The effect of alginate-hyaluronate microcapsules that release carboplatin in response to radiation was improved by adding ascorbic acid (AA).
MATERIALS AND METHODS:
Four measures of the effectiveness of the microcapsules were evaluated: 1) release of carboplatin in response to radiation in vitro and in vivo; 2) detectability of their accumulation by computed tomography (CT) in vivo; 3) enhancement of antitumor effects in vivo; and 4) reduction of adverse effects in vivo.
RESULTS:
There were significant increases in the rupture of microcapsules by adding AA in vitro. Subcutaneously injected microcapsules around the tumor could be detected by using CT and the alteration of CT-values correlated with the accumulation of the microcapsules. Those microcapsules released carboplatin and resulted in synergistic antitumor effect with concomitant radiation. With the encapsulation of carboplatin, chemotherapeutic effects were still observed two weeks after treatment. However, addition of AA did not result in increased antitumor effect in vivo. A reduction in adverse effects was observed with the encapsulation of carboplatin, through localization of carboplatin around the tumor.
CONCLUSION:
Addition of AA to the materials of microcapsules did not result in increasing antitumor effect. However encapsulation of carboplatin will be useful as a clinical cancer-therapy option.
AuthorsSatoshi Harada, Shigeru Ehara, Keizo Ishii, Takahiro Sato, Masashi Koka, Tomihiro Kamiya, Koichiro Sera, Shyoko Goto
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 70 Pg. 196-205 (Mar 2015) ISSN: 1950-6007 [Electronic] France
PMID25776501 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Capsules
  • Delayed-Action Preparations
  • Drug Carriers
  • Carboplatin
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Capsules (administration & dosage, radiation effects)
  • Carboplatin (administration & dosage, radiation effects)
  • Chemoradiotherapy (methods)
  • Delayed-Action Preparations (administration & dosage, radiation effects)
  • Drug Carriers (administration & dosage, radiation effects)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms (diagnostic imaging, therapy)
  • Tomography, X-Ray Computed
  • Xenograft Model Antitumor Assays (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: